Lovelace Medical Group

Christie White

Chief Operating Officer


Christie White, MBA, HCM- CMPE has more than 26 years of experience in healthcare, including both inpatient hospital and ambulatory operation management. She most recently served as assistant vice president of hospital operations for Lovelace Medical Group/Lovelace Medical Center/Lovelace Cancer Center. In this role, she has done an exceptional job managing all aspects of our hospital medicine services and ambulatory services, including the hospitalist program, medical oncology, radiation oncology, gamma-knife, infectious disease, and the neuro-hospitalist program.

Under Christie’s leadership, Lovelace opened the Monoclonal Antibody Therapy Clinic on a very short timeline. To date, the clinic has completed more than 900 treatments. In addition to leading the radiation oncology program to achieve ACR accreditation in 2017 and re-accreditation in 2020, Christie is preparing the Cancer Program for its 2023 Commission on Cancer (CoC) accreditation.

She received a bachelor of science degree in business administration and an MBA in healthcare management from University of Phoenix. Christie is a member of the board of directors for the New Mexico Cancer Research Alliance, and a member of the Society of Hospital Medicine, Society for Radiation Oncology Administrators and the American Society of Radiation Oncology Administrators.

Dr. John Cruickshank

Chief Executive Officer


John M. Cruickshank, D.O., MBA, CPE, joined Lovelace Health System in 2010. He served as Lovelace Health Plan’s Chief Medical Officer and then became the Chief Medical Officer for Lovelace Health System, responsible for medical management and quality for all six Lovelace hospitals and the physician group administrators. In June 2013, Dr. Cruickshank became the CEO of Lovelace Medical Group.

He has had a diverse and distinguished career in health care that spans nearly 30 years. Among his achievements, Dr. Cruickshank has helped lead physicians, hospitals and health plans in innovative efforts to improve quality and improve access to healthcare for New Mexicans. Since joining Lovelace in 2010, Dr. Cruickshank has played an instrumental role in the development of quality improvement efforts. In addition to a focus on quality measures and improvement across the health plan, he developed a five-touch approach for eliminating gaps in care for medically fragile members and has enhanced partnerships with providers to ensure quality care. Under his leadership, Lovelace Medical Group has grown to more than 200 providers and 24 clinic locations, with over 400,000 patient visits projected in 2019.

Before joining Lovelace, he served as Vice President and Market Medical Officer for Humana Healthcare in Phoenix, where he was responsible for medical operations in Arizona, Colorado, Nevada and Utah. Prior to that, Dr. Cruickshank was Executive Vice President and Chief Quality Officer at IASIS Healthcare in Franklin, Tenn. He also served at CIGNA Healthcare in Phoenix, where he directed operations for a 22-state region as its Western Region Chief Medical Officer.

Dr. Cruickshank was a Top CEO honoree in 2014 by Albuquerque Business First.

Dr. Cruickshank is board-certified in family medicine. He completed post-graduate training at the Chicago Osteopathic Medical Center, earning his Doctor of Osteopathic Medicine. He earned his Master of Business Administration from Arizona State University. Dr. Cruickshank is also board-certified in medical management (CPE) through the American College of Physician Executives.

Dr. Cruickshank has been a recipient of two prestigious awards from the United States Air Force for his distinguished service: the USAF Systems Command Flight Surgeon of the Year Award and the Meritorious Service Medal. He has honored his profession through participation and leadership in various medical associations, including the American Osteopathic Association, the Arizona Osteopathic Medical Association, the New Mexico Osteopathic Medical Society and the New Mexico Medical Society.